Answer
No. It is a monoclonal antibody that blocks RANKL. Both treatments reduce bone breakdown but work differently.
Sources for this answer
- Obodence 60 mg solution for injection in pre-filled syringe — Current selected SmPCemc · Summary of Product Characteristics
- Osenvelt 120mg vial — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.